Malaria in Africa

This project was a case study of malaria in Africa, specifically the Sub-Saharan region. The research poster will present the public health actions and results, as well as a set of recommendations for future efforts to promote the health of the high-risk people/population. The major health determinants for Africa are primarily poverty and lack of access to resources. The African region accounts for about 93% of malaria cases and 94% of malaria deaths worldwide (World Health Organization, 2020). Patients cannot afford preventive gear or necessary medication to help with the symptoms of malaria. Over the years there has been improvements in both prevention and development of medication. Vaccination development is still in progress but is something that is being worked towards. In recent years the number of malaria cases within Sub-Saharan Africa has fallen, which is a step in the right direction. In an effort to help, public health officials have increased production of preventative instruments, expanded testing and continued to work towards finding a vaccine. My recommendations on this matter are to improve access of preventative instruments to low income communities and greater distribution of anti-malarial drugs to those infected. Public health officials should focus on prevention of this infection to help the people of Africa now, rather than waiting and hoping on a vaccination, which may take many years to develop. Assisting in prevention and creating better access for these low-income communities is what I recommend for a public health action on this issue